Post job

TGen company history timeline

2002

On February 7, 2002 an assembly of more than fifty leaders and visionaries in science, medicine, government and business gathered at the Arizona state capitol to discuss the possibility of establishing Arizona as a player in the new economy of the biotechnology industry.

By April 2002, the task force had raised $80 million.

TGen officially launched in June 2002.

2005

Officials from TGen and the City of Phoenix joined with Senator Jon Kyl, Governor Janet Napolitano, Mayor Phil Gordon, and more than 500 guests to celebrate the building dedication and ribbon cutting in March 2005.

2013

The MindCrowd study (www.mindcrowd.org) began in 2013.

2016

In 2016, TGen joined City of Hope to make precision medicine a reality for all

2018

By August 2018, it had nearly 60,000 qualified participants, whose performance is reflected in the study.

2019

PHOENIX, Ariz. — June 18, 2019 — Results from a study of nearly 60,000 individuals suggest those at higher risk of developing Alzheimer’s disease due to family history may demonstrate changes in memory performance as early as their 20s.

2021

TGen identifies gene that could help prevent or delay onset of Alzheimer’s disease April 13, 2021

Work at TGen?
Share your experience
Founded
2002
Company founded
Headquarters
Phoenix, AZ
Company headquarter
Founders
Catherine E. Ivy,Sharon Harper
Company founders
Get updates for jobs and news

Rate TGen's efforts to communicate its history to employees.

Zippia waving zebra

TGen jobs

Do you work at TGen?

Is TGen's vision a big part of strategic planning?

TGen history FAQs

Zippia gives an in-depth look into the details of TGen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about TGen. The employee data is based on information from people who have self-reported their past or current employments at TGen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by TGen. The data presented on this page does not represent the view of TGen and its employees or that of Zippia.

TGen may also be known as or be related to TGEN, TGen, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, Tgen, Tgen Accelerators, Llc, The Translational Genomics Research Institute, Translational Genomics Research Institute and Translational Genomics Research Institute (TGen).